CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 45 enrolled
Drug / intervention
Genetic analyse by whole exome sequencingother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03831035
NCT03831035N/ACompleted

Fast Exome for Diagnosis of Congenital Conditions in Infants Under 12 Months of Age Hospitalized in Intensive Care Unit

University Hospital, Montpellier·observational·Posted Feb 5, 2019·Updated Nov 28, 2023

In Brief

An observational study evaluating Genetic analyse by whole exome sequencing for Infant, Newborn, Diseases and 3 related conditions. Completed, enrolled 45 participants across 1 site.

Detailed Summary

An early diagnosis of congenital malformations and suspected genetic conditions in critically ill infants is essential to perform specific adapted care, prevention, and give proper genetic counseling. However, etiologies are various and each of them is individually very rare. Thanks to next-generation sequencing technologies, diagnosis time frames have drastically decreased and the investigators have observed an increase in diagnosis yields. This study aims to evaluate the feasibility of fast trio exome sequencing (less than 16 days between informed consent signature and the consultation for results to the parents) in infants under the age of 12 months hospitalized in Intensive Care Unit (ICU).

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesFrance
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedFeb 5, 2019
Enrollment StartApr 8, 2019
Primary CompletionJun 8, 2022
TodayJul 2, 2026
Enrollment to primary: 3.2 yearsPosted 7.4 years ago

Interventions

Genetic analyse by whole exome sequencingother

Exome sequencing requires analytic, bio informatic and interpretation steps.